Monsenso A/S (CPH:MONSO)
Denmark · Delayed Price · Currency is DKK 0.1520
+0.0020 (1.33%)
Apr 15, 2026, 4:59 PM CET
Monsenso Market Cap
Monsenso has a market cap or net worth of 10.02 million as of April 15, 2026. Its market cap has decreased by -46.32% in one year.
Market Cap
10.02M
Enterprise Value
11.80M
Revenue
8.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
0.15
Market Cap Chart
Since June 10, 2020, Monsenso's market cap has decreased from 96.87M to 10.02M, a decrease of -89.66%. That is a compound annual growth rate of -32.18%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 13, 2026 | 10.02M | - |
| Dec 30, 2025 | 10.02M | -59.16% |
| Dec 30, 2024 | 24.52M | 177.63% |
| Dec 29, 2023 | 8.83M | -21.75% |
| Dec 30, 2022 | 11.29M | -59.30% |
| Dec 30, 2021 | 27.73M | -82.99% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Jun 10, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Novo Nordisk | 1.09T |
| Genmab | 113.14B |
| Coloplast | 96.78B |
| ALK-Abelló | 47.68B |
| Gubra | 5.49B |
| BioPorto | 442.63M |
| Pharma Equity Group | 104.59M |
| ViroGates | 101.17M |